Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Zhengzhou
Clinical trial register · China

Clinical Trials in Zhengzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Zhengzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Henan Cancer Hospital75 The First Affiliated Hospital of Zhengzhou University38 Merck Sharp & Dohme LLC28 AbbVie21 Novartis Pharmaceuticals20 Bristol-Myers Squibb19 Henan University of Traditional Chinese Medicine19 BeOne Medicines15 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.15 Henan Provincial People's Hospital14 AstraZeneca14 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.10 Ascentage Pharma Group Inc.10 Sun Yat-sen University9 Institute of Hematology & Blood Diseases Hospital, China8 Henan Institute of Cardiovascular Epidemiology8 Amgen8 Abbisko Therapeutics Co, Ltd8 Takeda7 Pfizer7 Beijing InnoCare Pharma Tech Co., Ltd.7 Fudan University7 Genmab7 Zhengzhou University7 Wecare Probiotics Co., Ltd.6 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.6 Hangzhou Sumgen Biotech Co., Ltd.5 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology5 Jiangsu HengRui Medicine Co., Ltd.5 Sichuan Baili Pharmaceutical Co., Ltd.5 Beijing Tiantan Hospital5 Hoffmann-La Roche5 Peking University People's Hospital5 The First Affiliated Hospital with Nanjing Medical University5 Peking Union Medical College Hospital5 Second Affiliated Hospital, Zhejiang University, School of Medicine5 Zhai Wenlong4 Allist Pharmaceuticals, Inc.4 China National Center for Cardiovascular Diseases4 Juventas Cell Therapy Ltd.4 First Affiliated Hospital of Zhejiang University4 Changchun GeneScience Pharmaceutical Co., Ltd.4 Nanjing Leads Biolabs Co.,Ltd4 Genfleet Therapeutics (Shanghai) Inc.4 InxMed (Shanghai) Co., Ltd.4 BeiGene4 Suzhou Zelgen Biopharmaceuticals Co.,Ltd4 Shanghai Chest Hospital4 Jiangsu Simcere Pharmaceutical Co., Ltd.4 Sir Run Run Shaw Hospital3 Mingzhi Zhang3 Shanghai Junshi Bioscience Co., Ltd.3 Nuvation Bio Inc.3 Hutchmed3 Nanfang Hospital, Southern Medical University3 Teligene US3 MediLink Therapeutics (Suzhou) Co., Ltd.3 Haihe Biopharma Co., Ltd.3 RemeGen Co., Ltd.3 Fujian Shengdi Pharmaceutical Co., Ltd.3 ADARx Pharmaceuticals, Inc.3 Shanghai Zhongshan Hospital3 Shanghai 10th People's Hospital3 Shandong Suncadia Medicine Co., Ltd.3 Astellas Pharma Global Development, Inc.3 Cancer Institute and Hospital, Chinese Academy of Medical Sciences3 Edwards Lifesciences3 Ausper Biopharma Co., Ltd.3 Seagen, a wholly owned subsidiary of Pfizer3 Eli Lilly and Company3 Dizal Pharmaceuticals3 Peking University Third Hospital3 MAXVAX Biotechnology Limited Liability Company3 Daiichi Sankyo3 Haisco Pharmaceutical Group Co., Ltd.3 Hansoh BioMedical R&D Company3 Loxo Oncology, Inc.3 Yongxu Jia3 Chinese Academy of Sciences3 Ruijin Hospital3 The Hong Kong Polytechnic University3 ArriVent BioPharma, Inc.3 Shanghai Pharmaceuticals Holding Co., Ltd3 Innovent Biologics (Suzhou) Co. Ltd.3 Qilu Hospital of Shandong University3 Risen (Suzhou) Pharma Tech Co., Ltd.2 Xuanwu Hospital, Beijing2 Suzhou BlueHorse Therapeutics Co., Ltd.2 Central China Fuwai Hospital of Zhengzhou University2 DK Medical Technology (Suzhou) Co., Ltd.2 Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.2 Jacobio Pharmaceuticals Co., Ltd.2 Shanghai Ming Ju Biotechnology Co., Ltd.2 Mabwell (Shanghai) Bioscience Co., Ltd.2 MSD R&D (China) Co., Ltd.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 RenJi Hospital2 Jiangsu BioJeTay Biotechnology Co., Ltd.2 Avistone Biotechnology Co., Ltd.2 Suzhou Immunofoco Biotechnology Co., Ltd2 UTC Therapeutics Inc.2 Zai Lab (Shanghai) Co., Ltd.2 Yanyan Liu2 Nanjing IASO Biotechnology Co., Ltd.2 DualityBio Inc.2 Celgene2 argenx2 Anhui Provincial Hospital2 Novo Nordisk A/S2 Peking University2 Beijing Chao Yang Hospital2 CARsgen Therapeutics Co., Ltd.2 Chigenovo Co., Ltd2 Hangzhou GluBio Pharmaceutical Co., Ltd.2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine2 Excyte Biopharma Ltd2 Eye & ENT Hospital of Fudan University2 Sinocelltech Ltd.2 Servier Bio-Innovation LLC2 Ningbo Rongan Biological Pharmaceutical Co., Ltd.2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Xuhua Duan2 Children's Hospital of Soochow University2 Henan Genuine Biotech Co., Ltd.2 Zhejiang University2 3D Medicines (Sichuan) Co., Ltd.2 Mirati Therapeutics Inc.2 Yingjuan Zheng2 TransThera Sciences (Nanjing), Inc.2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.2 Chengdu New Radiomedicine Technology Co. LTD.2 Xijing Hospital2 Suzhou Genhouse Bio Co., Ltd.2 Beijing Anzhen Hospital2 Candid Therapeutics2 Lee's Pharmaceutical Limited2 Eisai Inc.2 Huashan Hospital2 Akeso2 Shanghai Jiao Tong University School of Medicine2 China-Japan Friendship Hospital2 Daehwa Pharmaceutical Co., Ltd.1 Ying Gao1 Antengene Biologics Limited1 Shandong First Medical University1 Beijing Children's Hospital1 Bisirna Therapeutics (Suzhou) Co., Ltd.1 Fortvita Biologics (USA)Inc.1 Klus Pharma Inc.1 CryoLife, Inc.1 Zhigang Ren1 TJ Biopharma Co., Ltd.1 Epizyme, Inc.1 Shanghai Hongdian Medical CO., LTD1 ADC Therapeutics S.A.1 Jinzhou Medical University1 Celcuity Inc1 Jinling Hospital, China1 ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.1 Chengdu Kangnuoxing Biopharma,Inc.1 Hangzhou PhecdaMed Co., Ltd.1 Exelixis1 Acerand Therapeutics (Shanghai) Limited1 Beijing Biostar Pharmaceuticals Co., Ltd.1 Shanghai Xinzhi BioMed Co., Ltd.1 Changhai Hospital1 Central South University1 Philips Clinical & Medical Affairs Global1 Qilu Pharmaceutical Co., Ltd.1 Third Affiliated Hospital, Sun Yat-Sen University1 Keymed Biosciences Co.Ltd1 Lepu Medical Technology (Beijing) Co., Ltd.1 Junjie Xu1 Beijing Geekgene Technology Co., LTD1 Foresight Therapeutics (Hefei) Co., Ltd.1 Harbin Medical University1 Wayshine Biopharm, Inc.1 Lepu Biopharma Co., Ltd.1 Tongji Hospital1 Shanghai Best-Link Bioscience, LLC1 Shenzhen Ionova Life Sciences Co., Ltd.1 Fuling Zhou1 Incyte Corporation1 Jiangsu Aosaikang Pharmaceutical Co., Ltd.1 Beijing Jishuitan Hospital1 Shantou University Medical College1 Ranok Therapeutics (Hangzhou) Co., Ltd.1 Tianjin Medical University Cancer Institute and Hospital1 Peking University Cancer Hospital & Institute1 Xiamen Ophthalmology Center Affiliated to Xiamen University1 Fujian Medical University1 China Academy of Chinese Medical Sciences1 Second Affiliated Hospital of Nanchang University1 Vantive Health LLC1 Heronova Pharmaceuticals1 FrontAce Scientific Co., Ltd1 Shanghai Institute Of Biological Products1 Avenzo Therapeutics, Inc.1 Zhejiang Teruisi Pharmaceutical Inc.1 Third Affiliated Hospital of Zhengzhou University1 Du Zhenggui1 Abivax S.A.1 First Hospital of China Medical University1 Genrix (Shanghai) Biopharmaceutical Co., Ltd.1 Hinova Pharmaceuticals Inc.1 GeneQuantum Healthcare (Suzhou) Co., Ltd.1 Beijing Hospital1 Shanghai UniXell Biotechnology Co., Ltd1 Beijing QL Biopharmaceutical Co.,Ltd1 Chengdu SciMount Pharmatech Co., Ltd.1 Shenzhen Majory Biotechnology Co., Ltd.1 China Medical University, China1 Chunyan Ma1 Quanli Gao1 First Affiliated Hospital Xi'an Jiaotong University1 Biotheus Inc.1 Beijing Tide Pharmaceutical Co., Ltd1 Yi Shuhua1 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1 Bayer1 NucMito Pharmaceuticals Co. Ltd.1 Elpiscience (Suzhou) Biopharma, Ltd.1 PersonGen BioTherapeutics (Suzhou) Co., Ltd.1 Sanofi1 PharmaEssentia1 Sellas Life Sciences Group1 Advenchen Laboratories, LLC1 United Innomed(Shanghai) Limited1 Johnson & Johnson Medical (Shanghai) Ltd.1 Zenith Epigenetics1 InSilico Medicine Hong Kong Limited1 Suzhou Suncadia Biopharmaceuticals Co., Ltd.1 Southeast University, China1 Avistone Pharmaceutical(Ningbo)Co., LTD.1 Suzhou HepaThera Biotech Co., Ltd.1 West China Hospital1 Jiangsu Chuangyuan Life Science and Technology Co., Ltd.1 The First Affiliated Hospital of Soochow University1 Acerand Therapeutics (Hong Kong) Limited1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Peking University First Hospital1 Zhengzhou Children's Hospital, China1 Guangzhou Virotech Pharmaceutical Co., Ltd.1 Third Affiliated Hospital of Henan University of Traditional Chinese Medicine1 Geneplus-Beijing Co. Ltd.1 Xiangbo Wan1 Santen Pharmaceutical Co., Ltd.1 yilong Wang1 Guangzhou Excelmab Inc.1 Grit Biotechnology1 Xijing Hospital of Digestive Diseases1 Nanjing RegeneCore Biotech Co., Ltd.1 Children's Hospital of Fudan University1 Shanghai SciBrunch Therapeutics Co., Ltd.1 Dermavon Holdings Limited1 Viatris Pharmaceuticals Co., Ltd.1 Institut de Recherches Internationales Servier1 Chinese SLE Treatment And Research Group1 Shenzhen Genocury Biotech Co., Ltd.1 Jianning Yao1 Shenzhen Fosun Kairos Biotechnology Co., Ltd.1 BioSyngen Pte Ltd1 Ganzhou Hemay Pharmaceutical Co., Ltd1 Shanghai Ark Biopharmaceutical Co., Ltd.1 Phrontline Biopharma1 Boehringer Ingelheim1 Gang Wu1 Cascade Pharmaceuticals, Inc1 Shanghai Pulmonary Hospital, Shanghai, China1 Obstetrics & Gynecology Hospital of Fudan University1 GONGCHU Biotechnology Co., Ltd1 The Children's Hospital of Zhejiang University School of Medicine1 Huahui Health1 You Lu1 Heart Health Research Center1 GeneCradle Inc1 Capital Medical University1 Zhongnan Hospital1 Biogen1 CASI pharmaceuticals, Inc.1 Smith & Nephew, Inc.1 Changchun BCHT Biotechnology Co.1 Shanghai Jiaolian Drug Research and Development Co., Ltd1 Lining Xu1 Shubo Song1 Sichuan Huiyu Pharmaceutical Co., Ltd1 InnoBM Pharmaceuticals Co., Ltd.1 Tavotek Biotherapeutics1 Sinovac Life Sciences Co., Ltd.1 Shanghai Hengrui Pharmaceutical Co., Ltd.1 LG Chem1 Biotech Pharmaceutical Co., Ltd.1 Janssen Research & Development, LLC1 Yilai Shu1 Ascentawits Pharmaceuticals, Ltd1 Huabo Biopharm Co., Ltd.1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 Sino Medical Sciences Technology Inc.1 Genentech, Inc.1 Lyvgen Biopharma Holdings Limited1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 The Third Affiliated Hospital of Guangzhou Medical University1 Affiliated Hospital of Changchun University of Chinese Medicine1 BioNTech SE1 Zhenzhen Liu1 Shenzhen Core Medical Technology CO.,LTD.1 Newish Biotech (Wuxi) Co., Ltd.1 Broadenbio Ltd., Co.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.1 Xueyan Zhao1 The First People's Hospital of Changzhou1 I-Mab Biopharma US Limited1 Min Yan, MD1 Yongquan Shi1 Regeneron Pharmaceuticals1 Zhuhai Yufan Biotechnologies Co., Ltd1 Tong Chen, MD1 First Affiliated Hospital of Fujian Medical University1 Forward Pharmaceuticals Co., Ltd.1 Sinovac (Dalian) Vaccine Technology Co., Ltd.1 ZHOU FANGJIAN1 Sinotau Pharmaceutical Group1 Staidson (Beijing) Biopharmaceuticals Co., Ltd1 Novabio Therapeutics1 JIANGSU SHENMING Medical Technology CO., Ltd1 Juan Li1 Shenzhen Kexing Pharmaceutical Co., Ltd.1 Yi Zhang1 Shenyang Sunshine Pharmaceutical Co., LTD.1 Jiayuan Sun1 D3 Bio (Wuxi) Co., Ltd1 Gritgen Therapeutics Co., Ltd.1 Alebund Pharmaceuticals1 Qian Chu1 R1 Therapeutics1 Beijing Friendship Hospital1 YongZhang1 Affiliated Hospital of Liaoning University of Traditional Chinese Medicine1 Bivision Pharmaceuticals, Inc.1 Beijing Gene Key Life Technology Co., Ltd1 Betta Pharmaceuticals Co., Ltd.1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.1 Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd1 Longhua Hospital1 Hefei Xinzhu Biological Technology Co., Ltd.1 WeiShi1 VelaVigo Bio Inc1 Xiamen Amoytop Biotech Co., Ltd.1 Guangzhou Lupeng Pharmaceutical Company LTD.1 Shanghai MicroPort CardioFlow Medtech Co., Ltd.1 Suzhou Junjing BioSciences Co., Ltd.1 Alexion Pharmaceuticals, Inc.1 Ipsen1 Qiming Wang1 GeneSail Biotech (Shanghai) Co., Ltd.1 Clear sponsor filter
Site location
Zhengzhou1
All 1 locations
Target enrolment
to

Trials with a site in Zhengzhou

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer
NCT06670300Participants Who Had Received Second-line or Higher Advanced Melanoma and Advanced Renal Cancer
YongZhang
Phase 2
20
Zhengzhou
2024-12-01
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/zhengzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Zhengzhou that also match the filters currently applied.

How many clinical trials are recruiting in Zhengzhou?

0 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhengzhou), 1 studies
PhaseStudiesRecruitingShare
Phase 210100%

Most active sponsors

Lead sponsors with the most studies (Zhengzhou)
Lead sponsorStudiesRecruiting
YongZhang10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.